Camp4 Therapeutics earnings were -$107.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CAMP earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$33.5M, up 82.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CAMP reported annual earnings of -$80.4M, with 55.2% growth. The next CAMP earnings date is Nov 5, 2026.
What were Camp4 Therapeutics's earnings last quarter?
On CAMP's earnings call on Aug 13, 2026, Camp4 Therapeutics (NASDAQ: CAMP) reported Q2 2026 earnings per share (EPS) of -$0.58, up 6.45% year over year. Total CAMP earnings for the quarter were -$33.53 million. In the same quarter last year, Camp4 Therapeutics's earnings per share (EPS) was -$0.62.
The next CAMP earnings date is Nov 5, 2026. Add CAMP to your watchlist to be reminded of Camp4 Therapeutics's next earnings date.
Is Camp4 Therapeutics profitable or losing money?
As of the last Camp4 Therapeutics earnings report, Camp4 Therapeutics is currently losing money. Camp4 Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$107.24 million, a 107.1% increase year over year.
What was CAMP's earnings growth in the past year?
As of Camp4 Therapeutics's earnings date in Aug 13, 2026, Camp4 Therapeutics's earnings has grown year over year. CAMP earnings in the past year totalled -$107.24 million.
What are Camp4 Therapeutics's earnings expectations?
The current EPS estimate for Camp4 Therapeutics's earnings report in Nov 5, 2026 is -$0.19.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.